Emerade epinephrine auto-injectors are being recalled as a result of the units might fail.
Health Canada says the 0.3 and 0.5 milligram injectors might malfunction when individuals struggling a critical allergic response attempt to use them.
That means they may not get the epinephrine they should cease probably lethal anaphylaxis.
The recalled a lot of Emerade, produced by Quebec-based Bausch Health, had been distributed in Canada between April 2022 and May 2023.
Health Canada is urging individuals to take their Emerade auto-injectors to their pharmacies as quickly as doable to get a alternative.
They ought to speak to the pharmacist to verify they know the way to use the alternative machine earlier than leaving the pharmacy, the well being company says.
Health Canada says if somebody has a critical allergic response earlier than they’ll get a brand new machine, they need to nonetheless use the outdated one after which search emergency medical consideration.
Anyone with questions in regards to the recall can contact Bausch Health, Canada Inc. by calling 1-800-361-4261.
